Patient selection
breast lesions, breast neoplasia, papillomas, breast lesion
FIBROADENOMAS, PAPILLOMAS
Inclusion and exclusion criteria are presented in Table Inclusion and non-inclusion criteria• Female over 18 years old• Requiring conservative surgery for an histologically proven non-palpable breast lesion (fibroadenomas, papillomas, atypical lesions and neoplasia)• Speaking and understanding French• Patients referred to senology for localization of non-palpable breast lesions by surgeons• Affiliated to the French Social Security System• Able to give informed consent• Multiple breast lesions• Patients with breast neoplasia during pregnancy• Persons deprived of liberty or under guardianship or incapable of giving consent• Refusal to participateThe estimated duration of patients’ enrolment is 1 year and 6 months: 80 patients will be enrolled and followed from the inclusion until one month after surgery. A sequential inclusion in time will be performed: 20 inclusions in the control group (gold-standard) during 3 months, then 20 patients in the “RFID group” for the following 3 months with an interim statistical analysis, before repeating the inclusion scheme. When patients consent to participate in the study, they are informed of the device they will receive. Patients of the hookwire group are convened the day before the surgery to install the device. Patients with the RFID tag have the device installation at least one week before their surgery.